KRE29 Antibody

What is KRE29 and why is it important in research?

KRE29 is an essential protein subunit of the SMC5/6 complex in budding yeast. It functions alongside other proteins including Mms21, Smc5, Smc6, Nse1, and Qri2 as part of a nuclear multiprotein complex that affects DNA repair processes . KRE29 has been identified as a ~50-kDa protein of the ARM/HEAT repeat family, which includes subunits and regulators of cohesin and condensin complexes .

Research on KRE29 is particularly important because it has been implicated in cellular responses to DNA damage, with significant roles in maintaining genomic stability. Gene ontology analysis has shown KRE29 to be part of the cellular DNA damage stimulus response pathway, present in approximately 20.6% of genes involved in this process . Understanding KRE29's functions provides crucial insights into fundamental mechanisms of DNA repair and genome maintenance.

How does KRE29 function in the SMC5/6 complex?

KRE29 serves as one of the essential non-SMC subunits in the SMC5/6 complex of budding yeast. While KRE29 is not conserved at the primary sequence level in other species, it performs analogous functions to proteins like Nse6 in other organisms . The SMC5/6 complex plays critical roles in DNA repair, particularly in handling DNA damage during replication.

Within this complex, KRE29 appears to facilitate the DNA repair functions, potentially through mediating protein-protein interactions or affecting complex assembly. Research indicates that KRE29, like its functional counterpart Nse6, may form obligate heterodimers with other proteins in the complex that specifically facilitate the DNA repair roles of SMC5/6 .

What are the recommended methods for KRE29 protein detection?

For detecting KRE29 protein in research settings, immunoblotting (Western blotting) is the most commonly employed method. Based on established protocols in the literature, the following methodology is recommended:

• Sample preparation: Grow yeast strains to early log phase, with optional treatment with DNA damaging agents like methyl methanesulfonate (MMS) at 0.3% for 2 hours .

• Protein extraction: Prepare yeast lysates using standard protocols, typically involving mechanical disruption and detergent-based lysis buffers .

• SDS-PAGE separation: Resolve proteins on 8-12% SDS-PAGE gels depending on the specific experimental needs .

• Transfer and immunoblotting: Transfer proteins to Immobilon-P membranes, block with 5% milk in Tris-saline buffer with 0.3% Tween 20, and probe with appropriate antibodies .

For tagged versions of KRE29, monoclonal antibodies against common epitope tags (Myc, HA, FLAG) have been successfully used in various studies .

How can KRE29 antibodies be used to study protein-protein interactions within the SMC5/6 complex?

Studying protein-protein interactions involving KRE29 requires sophisticated immunoprecipitation techniques. Based on published methodologies, researchers can implement the following approach:

• Co-immunoprecipitation with tagged proteins: Generate yeast strains containing chromosomally tagged KRE29 (commonly with Myc, HA, or FLAG tags). Immunoprecipitate KRE29 using tag-specific antibodies conjugated to agarose beads, then identify interacting partners through mass spectrometry or immunoblotting for specific proteins of interest .

• Recombinant protein interaction studies: Express recombinant KRE29 alongside other SMC5/6 complex components in insect cells using baculovirus expression systems. For this approach:

  • Clone KRE29 cDNA into expression vectors containing appropriate tags (His6, HA, FLAG, or GST)

  • Generate recombinant baculoviruses and infect Sf9 insect cells

  • Co-express KRE29 with potential interaction partners

  • Perform FLAG purification or GST pulldown assays

  • Analyze bound proteins by SDS-PAGE and immunoblotting

These methods have successfully demonstrated interactions between components of the SMC5/6 complex and can be adapted to study KRE29's specific interaction network.

What are the best experimental approaches to study KRE29 function in DNA damage response?

To investigate KRE29's role in DNA damage response, researchers should consider multiple complementary approaches:

• Genetic interaction studies: Perform synthetic lethal screens or directed genetic crosses between KRE29 mutants and mutations in known DNA repair pathways. For example, studies have shown that combining mutations in the SMC5/6 complex with mutations in SUMO pathway components can reveal functional relationships .

• Replication stress response analysis: Treat cells with replication stress-inducing agents (MMS at 0.033% or hydroxyurea at 0.2M) and analyze replication intermediates using two-dimensional gel electrophoresis. This approach has been used successfully to study the functions of SMC5/6 complex components in handling replication stress .

• Chromatin immunoprecipitation (ChIP): Employ ChIP using KRE29 antibodies to identify genomic binding sites, particularly at sites of DNA damage or replication stress.

• Fluorescence microscopy: Use fluorescently tagged KRE29 to monitor its recruitment to sites of DNA damage in real-time or in fixed cells following damage induction.

• SUMO modification analysis: Since the SMC5/6 complex includes the SUMO ligase Mms21, assess whether KRE29 is subject to SUMO modification or influences the SUMOylation of other proteins in response to DNA damage .

How can researchers distinguish between direct and indirect effects when studying KRE29 function?

Distinguishing between direct and indirect effects of KRE29 remains challenging but can be approached through several methodological strategies:

• Domain-specific mutations: Generate specific mutations in functional domains of KRE29 rather than complete gene deletions. This approach allows researchers to separate different functions of the protein and determine which effects are directly mediated by specific activities of KRE29.

• Rapid protein depletion systems: Implement auxin-inducible degron (AID) or other rapid protein depletion systems to observe immediate consequences of KRE29 loss before secondary effects accumulate.

• In vitro reconstitution: Purify recombinant KRE29 and test its biochemical activities in defined in vitro systems. This approach can be particularly powerful when combined with structural studies to understand mechanistic details of KRE29 function.

• Temporal analysis: Perform time-course experiments following KRE29 depletion or inactivation to distinguish primary from secondary effects based on their timing.

• Separation-of-function alleles: Screen for mutants that affect specific aspects of KRE29 function while leaving others intact, helping to delineate which cellular phenotypes are directly dependent on particular KRE29 activities.

What are the optimal conditions for immunoprecipitation using KRE29 antibodies?

Optimizing immunoprecipitation (IP) conditions for KRE29 requires careful consideration of several parameters based on established protocols in the literature:

• Lysis buffer composition: Use buffers containing 25 mM HEPES (pH 7.4), 500 mM NaCl, 0.5 mM EDTA, 1.5 mM MgCl₂, 10% glycerol, and 0.05% Nonidet P-40, supplemented with protease inhibitor cocktails and 1 mM PMSF . This composition effectively solubilizes nuclear proteins while maintaining complex integrity.

• Cell disruption method: For yeast cells, combine freezing in liquid nitrogen with mechanical disruption (sonication with three pulses of 15 seconds at 70% output) to ensure complete lysis without denaturing protein complexes .

• Antibody binding conditions: Incubate cleared lysates with antibody-conjugated beads (e.g., anti-FLAG M2 affinity gel) for 2 hours at 4°C with rotation to ensure optimal antigen capture .

• Washing stringency: Perform multiple washes (typically three) with lysis buffer to remove non-specifically bound proteins while maintaining genuine interactions .

• Elution methods: For co-IP studies, elute bound proteins using either competitive elution (with epitope peptides) or denaturing conditions (SDS sample buffer), depending on downstream applications .

When working with tagged versions of KRE29, commercially available monoclonal antibodies against common epitope tags have shown high specificity and efficiency in immunoprecipitation experiments.

How should researchers validate KRE29 antibody specificity for their experiments?

Validation of KRE29 antibody specificity is critical for generating reliable experimental data. Based on standard practices in antibody validation, researchers should implement the following measures:

• Genetic controls: Include KRE29 deletion strains (when viable) or conditional mutants as negative controls in immunoblotting and immunoprecipitation experiments.

• Peptide competition assays: Pre-incubate the antibody with the immunizing peptide before application to samples. Specific signals should be competitively inhibited by this treatment.

• Multiple antibody comparison: When possible, utilize different antibodies recognizing distinct epitopes of KRE29 and compare the patterns obtained.

• Tagged protein controls: Compare signals from antibodies against endogenous KRE29 with those obtained using tag-specific antibodies in strains expressing tagged KRE29 versions.

• Mass spectrometry verification: Perform mass spectrometric analysis of immunoprecipitated material to confirm the presence of KRE29 and identify any potential cross-reactive proteins.

• Signal depletion with siRNA/CRISPR: In organisms where applicable, show that the antibody signal decreases following genetic depletion of KRE29.

What considerations are important when using KRE29 antibodies in different experimental organisms?

When applying KRE29 antibodies across different experimental systems, researchers should consider several important factors:

• Evolutionary conservation: KRE29 is not well-conserved at the primary sequence level across species . Therefore, antibodies raised against yeast KRE29 may not recognize functional homologs in other organisms. Instead, researchers should identify functional counterparts (such as Nse6 in fission yeast) and use antibodies specific to these proteins.

• Expression level differences: The expression level of KRE29 and its homologs may vary significantly between organisms and cell types, affecting detection sensitivity requirements.

• Epitope accessibility: Protein complex formation may mask antibody epitopes differently across species. Denaturation conditions may need adjustment when working with homologs from different organisms.

• Post-translational modifications: Patterns of post-translational modifications on KRE29 may differ between organisms, potentially affecting antibody recognition if the epitope includes modification sites.

• Background reactivity: Test antibodies for cross-reactivity with other proteins in the specific organism of interest, particularly with other members of the ARM/HEAT repeat family that share structural features with KRE29.

What are common challenges when detecting KRE29 in immunoblotting experiments?

Researchers frequently encounter specific challenges when working with KRE29 antibodies in immunoblotting applications. Based on the literature and common immunoblotting issues, these challenges and their solutions include:

• Low signal intensity: KRE29 may be expressed at relatively low levels in some cell types. To enhance detection:

  • Increase protein loading (up to 50-100 μg total protein)

  • Use more sensitive detection methods (ECL Prime or fluorescent secondary antibodies)

  • Extend primary antibody incubation (overnight at 4°C)

  • Consider using tagged versions of KRE29 for enhanced detection

• High molecular weight smears: These may represent SUMOylated or otherwise modified forms of KRE29, as the SMC5/6 complex is associated with SUMO modification machinery . To distinguish these forms:

  • Run longer SDS-PAGE gels with better resolution in the high molecular weight range

  • Perform immunoprecipitation followed by detection with SUMO-specific antibodies

  • Include SUMO protease inhibitors like N-ethylmaleimide (NEM) in lysis buffers

• Multiple bands or non-specific binding: To improve specificity:

  • Increase blocking time and concentration (5% milk or BSA, overnight if necessary)

  • Include additional washing steps with higher detergent concentrations

  • Pre-absorb antibody with lysates from KRE29 deletion strains (where applicable)

• Inconsistent results: To improve reproducibility:

  • Standardize growth conditions and cell harvesting protocols

  • Prepare fresh lysates immediately before experiments

  • Include positive controls (tagged KRE29) in each experiment

  • Maintain consistent protein extraction, transfer, and detection conditions

How can researchers optimize KRE29 immunoprecipitation from different cellular compartments?

KRE29 is primarily a nuclear protein associated with chromatin through the SMC5/6 complex. Optimizing its immunoprecipitation from different cellular compartments requires specific approaches:

• Nuclear extraction optimization:

  • Perform gentle cell lysis to isolate intact nuclei before nuclear protein extraction

  • Use low concentrations of detergents (0.05% NP-40 or Triton X-100) in initial lysis

  • Add nucleases (Benzonase or DNase I) to release chromatin-bound proteins

  • Consider using specialized nuclear extraction kits that preserve protein complexes

• Chromatin-bound fraction isolation:

  • Implement stepwise extraction protocols that separate soluble nuclear proteins from chromatin-bound factors

  • Use increasing salt concentrations (0.3M to 0.5M NaCl) to extract different chromatin-associated protein fractions

  • For tightly bound proteins, include sonication steps to fragment chromatin

• Preserving protein complex integrity:

  • Add protein crosslinking agents (formaldehyde or DSP) before extraction to stabilize transient interactions

  • Include phosphatase inhibitors (sodium fluoride, sodium orthovanadate) alongside protease inhibitors

  • Maintain samples at 4°C throughout all processing steps

  • Consider native extraction conditions that preserve the SMC5/6 complex structure

• Solubilization challenges:

  • Test different detergent combinations (CHAPS, digitonin, or sodium deoxycholate) if standard NP-40 extraction is inefficient

  • For difficult-to-extract chromatin fractions, consider brieft treatment with micrococcal nuclease to fragment DNA without disrupting protein complexes

What novel techniques could enhance KRE29 research using antibodies?

Several emerging technologies could significantly advance KRE29 research when combined with specific antibodies:

• Proximity labeling techniques: Employing BioID or APEX2 fusions with KRE29 would allow identification of proximal proteins in living cells, potentially revealing transient or weak interactions not captured by traditional co-immunoprecipitation approaches.

• Super-resolution microscopy: Combining highly specific KRE29 antibodies with techniques like STORM, PALM, or expansion microscopy could reveal precise subcellular localization patterns and co-localization with other DNA repair factors at unprecedented resolution.

• CUT&RUN or CUT&Tag approaches: These techniques offer advantages over traditional ChIP by providing higher signal-to-noise ratios and requiring fewer cells, potentially allowing more detailed mapping of KRE29 association with chromatin.

• Single-cell protein analysis: Adapting techniques like single-cell Western blotting or mass cytometry with KRE29 antibodies could reveal cell-to-cell variability in KRE29 expression or modification states following DNA damage.

• CRISPR-based tagging strategies: Using homology-directed repair to insert split fluorescent proteins or enzymatic tags at the endogenous KRE29 locus would enable tracking of native KRE29 dynamics without overexpression artifacts.

How might structural studies inform better KRE29 antibody design?

Structural studies of KRE29 could significantly enhance antibody design and experimental applications through several avenues:

• Epitope mapping: Detailed structural information would identify surface-exposed regions ideal for raising antibodies that recognize native KRE29 in complex with other SMC5/6 components.

• Domain-specific antibodies: Structural insights would enable generation of antibodies targeting specific functional domains, potentially allowing selective inhibition of particular KRE29 activities.

• Conformation-specific antibodies: Understanding structural changes in KRE29 during different functional states could lead to antibodies that specifically recognize active, inactive, or intermediate conformations.

• Complex-specific epitopes: Structural studies of the entire SMC5/6 complex could reveal interface regions unique to KRE29 within the assembled complex, enabling development of antibodies that specifically recognize complex-associated KRE29.

• Post-translational modification sites: Mapping modification sites structurally would allow generation of modification-specific antibodies that could serve as readouts for KRE29 activity or regulation.